DK38895A - Acetyleniske imidazolderivater samt farmaceutisk præparat indeholdende disse - Google Patents

Acetyleniske imidazolderivater samt farmaceutisk præparat indeholdende disse Download PDF

Info

Publication number
DK38895A
DK38895A DK038895A DK38895A DK38895A DK 38895 A DK38895 A DK 38895A DK 038895 A DK038895 A DK 038895A DK 38895 A DK38895 A DK 38895A DK 38895 A DK38895 A DK 38895A
Authority
DK
Denmark
Prior art keywords
disorders
methyl
ethyl
hydrogen
acetylenic
Prior art date
Application number
DK038895A
Other languages
English (en)
Inventor
Malcolm W Moon
Richard F Heier
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DK38895A publication Critical patent/DK38895A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK038895A 1988-07-25 1995-04-05 Acetyleniske imidazolderivater samt farmaceutisk præparat indeholdende disse DK38895A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22357688A 1988-07-25 1988-07-25

Publications (1)

Publication Number Publication Date
DK38895A true DK38895A (da) 1995-04-05

Family

ID=22837101

Family Applications (3)

Application Number Title Priority Date Filing Date
DK008791A DK8791A (da) 1988-07-25 1991-01-18 Acetyleniske imidazolderivater samt farmaceutisk praeparat indeholdende disse
DK038895A DK38895A (da) 1988-07-25 1995-04-05 Acetyleniske imidazolderivater samt farmaceutisk præparat indeholdende disse
DK038995A DK38995A (da) 1988-07-25 1995-04-05 Acetyleniske imidazolderivater samt farmaceutisk præparat indeholdende disse

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK008791A DK8791A (da) 1988-07-25 1991-01-18 Acetyleniske imidazolderivater samt farmaceutisk praeparat indeholdende disse

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK038995A DK38995A (da) 1988-07-25 1995-04-05 Acetyleniske imidazolderivater samt farmaceutisk præparat indeholdende disse

Country Status (8)

Country Link
EP (1) EP0426714B1 (da)
JP (1) JPH03506032A (da)
KR (1) KR900701761A (da)
AT (1) ATE136300T1 (da)
AU (1) AU620894B2 (da)
DE (1) DE68926165D1 (da)
DK (3) DK8791A (da)
WO (1) WO1990001026A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137905A (en) * 1988-10-27 1992-08-11 The Upjohn Company Heterocyclic acetylenic amines having central nervous system activity
US5550257A (en) * 1991-04-24 1996-08-27 American Cyanamid Company Substituted oxotremorine derivatives
US5356885A (en) * 1991-04-24 1994-10-18 American Cyanamid Company Substituted oxotremorine derivatives and pharmaceutical use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1245743A (en) * 1967-11-09 1971-09-08 Astra Ab Alkynyl lactams
EP0117462A3 (en) * 1983-02-28 1986-08-20 American Cyanamid Company N-(2-4-(1h-imidazol-1-yl)alkyl)arylamides
ZA84949B (en) * 1983-04-06 1984-09-26 American Cyanamid Co Substituted-n-(2-4-(1h-imidazol-1-yl)alkyl)substituted amides

Also Published As

Publication number Publication date
ATE136300T1 (de) 1996-04-15
JPH03506032A (ja) 1991-12-26
AU620894B2 (en) 1992-02-27
EP0426714A1 (en) 1991-05-15
AU3877789A (en) 1990-02-19
KR900701761A (ko) 1990-12-04
WO1990001026A1 (en) 1990-02-08
DK8791D0 (da) 1991-01-18
DK8791A (da) 1991-01-18
DK38995A (da) 1995-04-05
EP0426714B1 (en) 1996-04-03
DE68926165D1 (de) 1996-05-09

Similar Documents

Publication Publication Date Title
HUP0102084A2 (hu) Kinolinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
SE0104334D0 (sv) Therapeutic agents
HUP9900172A2 (hu) Idegrendszeri elváltozások kezelésére alkalmas 10-aciloxi-10,11-dihidrobenz/b,f/azepin-5-karboxamid, előállítása és ezt tartalmazó gyógyszerkészítmény
HUP0300846A2 (hu) Imidazopirimidin- és triazolopirimidin-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyszerkészítmények
ATE173257T1 (de) Heterocyclische verbindungen und ihre herstellung und verwendung
HUP0101130A2 (hu) Aminoindánszármazékok és ezeket tartalmazó gyógyászati készítmények
MA27079A1 (fr) Derives 1, 6-naphthyridine et leur utilisation dans le traitement du diabete et de troubles associes
HUP0002031A2 (hu) Benzotiofénszármazékok alkalmazása központi idegrendszeri betegségek kezelésére szolgáló gyógyszerkészítmények előállítására
ATE8874T1 (de) Therapeutisch nuetzliche 1-alkyl-2-amino-tetralin- derivate.
ES8706670A1 (es) Un procedimiento para preparar 1,4-dihidropiridinas
AU4210989A (en) Heterocyclic acetylenic amines having central nervous system activity
KR900001693A (ko) 아자사이클릭 화합물, 이의 제조방법 및 이의 용도
DK38895A (da) Acetyleniske imidazolderivater samt farmaceutisk præparat indeholdende disse
ZA922625B (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
ATE160566T1 (de) Amphotere tricyclische verbindungen als antihistaminische und antiallergische mittel
HUP0302820A2 (hu) CNS rendellenességek kezelésében hasznos indolszármazékok és ezeket tartalmazó gyógyszerkészítmények
DE69925160D1 (de) Arylpiperidin- und aryl-1,2,5,6-tetrahydropyridinamid-derivate mit 5ht1a rezeptor aktivität
DK0853478T3 (da) Nye N-acylerede 4-hydroxyphenylaminderivater med analgetiske egenskaber samt farmaceutiske sammensætninger indeholdende disse
BE1002181A3 (fr) 3-(2-haloalkyl)-1,4-oxathiines et 2-(2-haloalkyl)-1,4-dithiines, de meme que le traitement de la leucemie et des tumeurs avec ces substances.
HUP0000854A2 (hu) 4-[6-Fluor-(1H)-indol-3-il]-1,2,3,6-tetrahidropiridin-származékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás mindezek előállítására
ZA891769B (en) Heterocyclic compounds
HUP0004671A2 (hu) 5-Szubsztituált-3-oxadiazolil-1,6-naftiridin-2(1H)-on-származékok és ezeket tartalmazó gyógyszerkészítmények
ATE42291T1 (de) Spiro(indolo(1,7-ab>(1,5>benzodiazepin-2,4'piperidine> und zwischenprodukte, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.
HUP0002895A2 (hu) 3-Azabiciklo[3.1.0]hexánok, eljárás előállításukra és alkalmazásuk
ATE56705T1 (de) Piperidinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment